3D4Q | pdb_00003d4q

Pyrazole-based inhibitors of B-Raf kinase


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free: 
    0.250 (Depositor), 0.241 (DCC) 
  • R-Value Work: 
    0.216 (Depositor), 0.214 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 3D4Q

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Potent and selective pyrazole-based inhibitors of B-Raf kinase.

Hansen, J.D.Grina, J.Newhouse, B.Welch, M.Topalov, G.Littman, N.Callejo, M.Gloor, S.Martinson, M.Laird, E.Brandhuber, B.J.Vigers, G.Morales, T.Woessner, R.Randolph, N.Lyssikatos, J.Olivero, A.

(2008) Bioorg Med Chem Lett 18: 4692-4695

  • DOI: https://doi.org/10.1016/j.bmcl.2008.07.002
  • Primary Citation Related Structures: 
    3D4Q

  • PubMed Abstract: 

    Herein we describe a novel pyrazole-based class of ATP competitive B-Raf inhibitors. These inhibitors exhibit both excellent cellular potency and striking B-Raf selectivity. A subset of these inhibitors has demonstrated the ability to inhibit downstream ERK phosphorylation in LOX tumors from mouse xenograft studies.


  • Organizational Affiliation
    • Lead Optimization, Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, USA. josh.hansen@arraybiopharma.com

Macromolecule Content 

  • Total Structure Weight: 71.18 kDa 
  • Atom Count: 4,293 
  • Modeled Residue Count: 528 
  • Deposited Residue Count: 614 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
B-Raf proto-oncogene serine/threonine-protein kinase
A, B
307Homo sapiensMutation(s): 0 
Gene Names: BRAFBRAF1RAFB1
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P15056 (Homo sapiens)
Explore P15056 
Go to UniProtKB:  P15056
PHAROS:  P15056
GTEx:  ENSG00000157764 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP15056
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
SM5

Query on SM5



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
C22 H23 N5 O
KWEFZSZCLBHIEQ-YYADALCUSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free:  0.250 (Depositor), 0.241 (DCC) 
  • R-Value Work:  0.216 (Depositor), 0.214 (DCC) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 100.343α = 90
b = 100.343β = 90
c = 162.536γ = 90
Software Package:
Software NamePurpose
CNSrefinement
PDB_EXTRACTdata extraction
ADSCdata collection
DENZOdata reduction
SCALEPACKdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-08-19
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2018-01-24
    Changes: Structure summary
  • Version 1.3: 2024-02-21
    Changes: Data collection, Database references, Derived calculations